FGF R2 (IIIc)產(chǎn)品信息
英文名稱:Fibroblast growth factor receptor 2
中文名稱:成纖維細(xì)胞生長因子受體-2
靶點(diǎn)別稱:FGF R2 (IIIc),FGFR2B,FGFR2
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 . Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
FGF R2 (IIIc)分子背景
酪氨酸蛋白激酶作為成纖維細(xì)胞生長因子的細(xì)胞表面受體,在細(xì)胞增殖、分化、遷移和凋亡的調(diào)節(jié)以及胚胎發(fā)育的調(diào)節(jié)中起著至關(guān)重要的作用。正常胚胎模式、滋養(yǎng)層功能、肢芽發(fā)育、肺形態(tài)發(fā)生、成骨和皮膚發(fā)育所需。在成骨細(xì)胞分化、增殖和凋亡的調(diào)節(jié)中起著至關(guān)重要的作用,是正常骨骼發(fā)育所必需的。促進(jìn)角質(zhì)形成細(xì)胞和未成熟成骨細(xì)胞的細(xì)胞增殖,但促進(jìn)分化的成骨細(xì)胞凋亡。磷酸PLCG1、FRS2和PAK4。配體結(jié)合導(dǎo)致幾個信號級聯(lián)的激活。PLCG1的激活導(dǎo)致細(xì)胞信號分子二?;视秃图〈?/span>1,4,5-三磷酸的產(chǎn)生。FRS2的磷酸化觸發(fā)GRB2、GAB1、PIK3R1和SOS1的募集,并介導(dǎo)RAS、MAPK1/ERK2、MAPK3/ERK1和MAP激酶信號通路以及AKT1信號通路的激活。FGFR2信號傳導(dǎo)受到泛素化、內(nèi)化和降解的下調(diào)。導(dǎo)致組成型激酶激活或損害正常FGFR2成熟、內(nèi)化和降解的突變會導(dǎo)致異常信號傳導(dǎo)。過度表達(dá)的FGFR2促進(jìn)STAT1的激活。
關(guān)鍵字: FGF R2 (IIIc);FGF R2 (IIIc)蛋白;FGFR2;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。